Developing and mature oligodendrocytes respond differently to the immune cytokine interferon-gamma

Journal of Neuroscience Research

Volumn 52, Issue 2, 1998, Pages 230-239

  Baerwald, Kristine D ^a,b   Popko, Brian ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Apoptosis; Cytokine; Development; Myelination; Necrosis

Indexed keywords

CYTOKINE; GAMMA INTERFERON;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL MATURATION; DEMYELINATING DISEASE; IMMUNE RESPONSE; KILLER CELL; MACROPHAGE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MYELINATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REMYELINIZATION;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INTERFERON TYPE II; MYELIN SHEATH; NECROSIS; OLIGODENDROGLIA; RATS;

EID: 0032522813     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19980415)52:2<230::AID-JNR11>3.0.CO;2-B     Document Type: Article

References (60)

1. Abramsky O (1982): Oligodendrocytes: the putative target cells of multiple sclerosis. Is J Med Sci 18:149-158.
2. Agresti C, D'Urso D, Levi G (1996): Reversible inhibitory effects of interferon-gamma and tumour necrosis factor-α on oligodendroglial lineage cell proliferation and differentiation in vitro. Eur J Neurosci 8:1106-1116.
3. Armstrong R, Friedrich VL, Jr, Holmes KV, Dubois-Dalcq M (1990): In vitro analysis of the oligodendrocyte lineage in mice during demyelination and remyelination. J Cell Biol 111:1183-1195.
4. Bansal R, Warrington AE, Gard AL, Ranscht B, Pfeiffer SE (1989): Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development. J Neurosci Res 24:548-557.
5. Bartlett PF, MacKay IR (1983): The oligodendroglial cell: biology and immunology and relationship to multiple sclerosis. J Clin Lab Immunol 11:1-7.
6. Benveniste EN, Benos DJ (1995): TNF-α and IFN-gamma-mediated signal transduction pathways: effects on glial cell gene expression and function. FASEB J 9:1577-1584.
7. Bernier L, Alvarez F, Norgard EM, Raible DW, Mentaberry A, Schembri JG, Sabatini DD, Colman DR (1987): Molecular cloning of a 2′,3′-cyclic nucleotide 3′-phosphodiesterase: mRNAs with different 5′ ends encode the same set of proteins in nervous and lymphoid tissues. J Neurosci 7:2703-2710.
8. Billiau A, Heremans H, Vandekerckhove F, Dijkmans R, Sobis H, Meulepas E, Carton H (1988): Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. J Immunol 140:1506-1510.
9. Calder VL, Wolswijk G, Noble M (1988): The differentiation of O-2A progenitor cells into oligodendrocytes is associated with a loss of inducibility of Ia antigens. Eur J Immunol 18:1195-1201.
10. Carroll WM, Jennings AR (1994): Early recruitment of oligodendrocyte precursors in CNS demyelination. Brain 117:563-578.
11. Corbin JG, Kelly D, Rath EM, Baerwald KD, Suzuki K, Popko B (1996): Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development. Mol Cell Neurosci 7:354-370.
12. Dubois-Dalcq M, Armstrong R (1990): The cellular and molecular events of central nervous system remyelination. Bioessays 12:569-576.
13. Dubois-Dalcq M, Armstrong RC (1992): The oligodendrocyte lineage during myelination and remyelination. In Martenson RE (ed): "Myelin: Biology and Chemistry." Boca Raton: CRC Press., pp 81-122.
14. Duong TT, St. Louis J, Gilbert JJ, Finkelman FD, Strejan GH (1992): Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J Neuroimmunol 36:105-115.
15. Edelstein SJ, Bollag DM (1991): Gel electrophoresis under denaturing conditions. In Edelstein SJ, Bollag DM (eds): "Protein Methods." New York: Wiley-Liss, Inc., pp 95-142.
16. Ferber IA, Brocke S, Taylor-Edwards C, Ridgway W, Dinisco C, Steinman L, Dalton D, Fathman CG (1996): Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 156:5-7.
17. Fujita N, Sato S, Kurihara T, Inuzuka T, Takahashi Y, Miyatake T (1988): Developmentally regulated alternative splicing of brain myelin-associated glycoprotein mRNA is lacking in the quaking mouse. FEBS Lett 232:323-327.
18. Gehrmann J, Gold R, Linington C, Lannes-Vieira J, Wekerle H, Kreutzberg GW (1993): Microglial involvement in experimental autoimmune inflammation of the central and peripheral nervous system. Glia 7:50-59.
19. Horwitz MS, Evans CF, McGavern DB, Rodriguez M, Oldstone MBA (1997): Primary demyelination in transgenic mice expressing interferon-gamma. Nature Med 3:1037-1041.
20. Huang S, Hendriks W, Althage A, Hemmi S, Bleuthmann H, Kamijo R, Vilcek J, Zinkernagel RM, Aguet M (1993): Immune response in mice that lack the interferon-gamma receptor. Science 259:1742-1745.
21. Ingraham CA, McCarthy KD (1989): Plasticity of process-bearing glial cell cultures from neonatal rat cerebral cortical tissue. J Neurosci 9:63-69.
22. Karpus WJ, Swanborg RH (1989): CD4+ suppressor cells differentially affect the production of IFN-gamma by effector cells of experimental autoimmune encephalomyelitis. J Immunol 143: 3492-3497.
23. Levison SW, McCarthy KD (1991): Astroglia in culture. In Banker G, Gosslin K (eds): "Culturing Nerve Cells." Cambridge: MIT Press, pp 309-336.
24. Livant D, Blatt C, Hood L (1986): One heavy chain variable region segment subfamily in the BALB/c mouse contains 500-1000 or more members. Cell 47:461-470.
25. Massa PT, Ozato K, McFarlin DE (1993): Cell type-specific regulation of major histocompatibility complex (MHC) class I gene expression in astrocytes, oligodendrocytes, and neurons. Glia 8:201-207.
26. McCarthy KD, de Vellis J (1980): Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902.
27. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE (1993): Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 151:2132-2141.
28. Miller SD, McRae BL, Vanderlugt CL, Nikcevich KM, Pope JG, Pope L, Karpus WJ (1995): Evolution of the T-cell repertoire during the course of experimental immune-mediated demyelinating diseases. Immunol Rev 144:225-244.
29. Milner RJ, Lai C, Nave KA, Lenoir D, Ogata J, Sutcliff JG (1985): Nucleotide sequences of two mRNAs for rat brain myelin proteolipid protein. Cell 10:931-939.
30. Mitrovic B, Ignarro LJ, Vinters HV, Akers M-A, Schmid I, Uittenbogaart C, Merrill JE (1995): Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes. Neuroscience 65:531-539.
31. Ozawa K, Suchanek G, Breitschopf H, Bruck W, Budka H, Jellinger K, Lassmann H (1994): Patterns of oligodendroglia pathology in multiple sclerosis. Brain 117:1311-1322.
32. Panitch HS (1992): Interferons in multiple sclerosis. Drugs 44:946-962.
33. Panitch HS, Hirsch RL, Schindler J, Johnson KP (1987): Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 37:1097-1102.
34. Piechaczyk M, Blanchard JM, Many L, Dani C, Panabieres F, Sabouty SE, Fort P, Jeanteur P (1984): Post-transcriptional regulation of glyceraldehyde-3-phosphate-dehydrogenase gene expression in rat tissues. Nucleic Acids Res 12:6951-6963.
35. Popko B, Puckett C, Lai E, Shine HD, Readhead C, Takahashi N, Hunt SW, III, Sidman RL, Hood L (1987): Myelin deficient mice: expression of myelin basic protein and generation of mice with varying levels of myelin. Cell 48:713-721.
36. Popko B, Corbin JG, Baerwald KD, Dupree J, Garcia AM (1997): The effects of interferon-gamma on the central nervous system. Mol Neurobiol 14:19-35.
37. Prineas JW (1975): Pathology of the early lesion in multiple sclerosis. Hum Pathol 6:531-554.
38. Prineas JW (1985): The neuropathology of multiple sclerosis. In Koetsier JC (ed): "Handbook of Clinical Neurology." Amsterdam: Elsevier Science, pp 213-257.
39. Raine CS (1994): The Dale E. McFarlin memorial lecture: the immunology of the multiple sclerosis lesion. Ann Neurol 36:S61-S72.
40. Roach A, Boylan K, Horvath S, Prusinar SB, Hood LE (1983): Characterization of cloned cDNA representing rat myelin basic protein: absence of expression in brain shiverer mutant mice. Cell 74:799-806.
41. Rodriguez M, Miller DJ (1994): Immune promotion of central nervous system remyelination. Prog Brain Res 103:343-355.
42. Rodriguez M, Scheithauer B (1994): Ultrastructure of multiple sclerosis. Ultrastruct Pathol 18:3-13.
43. Rodriguez M, Scheithauer BW, Forbes G, Kelly PJ (1993): Oligodendrocyte injury is an early event in lesions of multiple sclerosis. Mayo Clinic Proc 68:627-636.
44. Roland M, McFarland HF (1995): Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sci 32:121-182.
45. Satoh J, Kim SU, Kastrukoff LF, Takei F (1991): Expression and induction of intercellular adhesion molecules (ICAMs) and major histocompatibility complex (MHC) antigens on cultured murine oligodendrocytes and astrocytes. J Neurosci Res 29: 1-12.
46. Schneider-Schaulies J, Kirchhoff F, Archelos J, Schachner M (1991): Down-regulation of myelin-associated glycoprotein on Schwann cells by interferon-gamma and tumor necrosis factor-α affects neurite outgrowth. Neuron 7:995-1005.
47. Sommer I, Schachner M (1981): Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system. Dev Biol 83:311-327.
48. Stahl N, Harry J, Popko B (1990): Quantitative analysis of myelin protein gene expression during development in the rat sciatic nerve. Mol Brain Res 8:209-212.
49. Stahl N, Jurevics H, Morell P, Suzuki K, Popko B (1994): Isolation, characterization, and expression of cDNA clones that encode rat UDP-galactose:ceramide galactosyltransferase. J Neurosci Res 38:234-242.
50. Sutcliffe JG, Milner RJ, Shinnick TM, Bloom FE (1983): Identifying the protein products of brain-specific genes with antibodies to chemically synthesized peptides. Cell 33:671-682.
51. Suzumura A, Silberberg DH, Lisak RP (1986): The expression of MHC antigens on oligodendrocytes: induction of polymorphic H-2 expression by lymphokines. J Neuroimmunol 11:179-190.
52. Turnley AM, Miller JFAP, Bartlett PF (1991): Regulation of MHC molecules on MBP positive oligodendrocytes in mice by IFN-γ and TNF-α. Neuroscience Letters 123:45-48.
53. Vartanian T, Li Y, Zhao M, Stefansson K (1995): Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol Med 1:732-743.
54. Vaux DL (1993): Toward and understanding of the molecular mechanisms of physiological cell death. Proc Nat Acad Sci USA 90:786-789.
55. Vilcek J, Gray PW, Rinderknecht E, Sevastopoulos CG (1985): Interferon gamma: a lymphokine for all seasons. Lymphokines 11:1-32.
56. Voorthius JAC, Uitdehaag BMJ, De Groot CJA, Goede PH, Van Der Meide PH, Dijkstra CD (1990): Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats. Clin Exp Immunol 81:183-188.
57. Wheelock EF (1965): Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin. Science 149:310-311.
58. Wilt SG, Milward E, Zhou JM, Nagasato K, Patton H, Rusten R, Griffin DE, O'Connor M, Dubois-Dalcq M (1995): In vitro evidence for a dual role of tumor necrosis factor-α in human immunodeficiency virus type 1 encephalopathy. Ann Neurol 37:381-394.
59. Wong GHW, Bartlett PF, Clark-Lewis I, Battye F, Schrader JW (1984): Inducible expression of H-2 and Ia antigens on brain cells. Nature 310:688-691.
60. Zajicek JP, Wing M, Scolding MJ, Compston DAS (1992): Interactions between oligodendrocytes and microglia: a major role for complement and tumour necrosis factor in oligodendrocyte adherence and killing. Brain 115:1611-1631.